Diseases

Group Association

Treatment details

Novartis Europharm Limited

Sponsor:

Novartis Europharm Limited

Generic Name:

(2-aminoethyl) carbamic acid (2R,5S,8S,11S,14R,17S,19aS)-11-(4-aminobutyl)-5-benzyl-8-(4-benzyloxy benzyl)-14-(1H-indol-3-ylmethyl)-4,7,10,13,16,19-hexaoxo-17-phenyloctadecahydro-3a,6,9,12,15,18-hexaazacyclopentacyclooctadecen-2-yl ester, di[(S)-2-aminosu

Trade Name

Update this field

Designated Indication:

Treatment of functional gastro-entero-pancreatic endocrine tumours

Disease(s):

Update this field

Disease(s) Synonyms:

Update this field

Indication Approved for Marketing:

Update this field

Date Approved (EU):

11/30/-0001

Designation Date (EU):

11/30/-0001

Date Approved (US):

11/30/-0001

Designation Date (US):

11/30/-0001

Additional Approved Countries:

Update this field

Companies Overview:

Update this field

Homepage:

www.novartis.com

Address 1:

Update this field

Address 2:

Update this field

Country:

Update this field

City:

Update this field

Posted by CheckOrphan at 01/01/1970